Here is a fine review of what's happened the last several days in the debate over which stem cell course the U.S. government should help finance: one which has already paid off in many successful treatments and which promises many more in the months ahead, or one which has been over-hyped, over-sold and which hasn't yet produced a single successful medical treatment.
And, oh yeah; the second choice also requires human embryos to be killed.
The piece is from the Center for a Just Society and can be read right here.
